GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Erech Finance Cahalacha Ltd (XTAE:EFNC) » Definitions » EV-to-Revenue

Erech Finance Cahalacha (XTAE:EFNC) EV-to-Revenue : 79.89 (As of Jun. 24, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Erech Finance Cahalacha EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Erech Finance Cahalacha's enterprise value is ₪22.53 Mil. Erech Finance Cahalacha's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₪0.28 Mil. Therefore, Erech Finance Cahalacha's EV-to-Revenue for today is 79.89.

The historical rank and industry rank for Erech Finance Cahalacha's EV-to-Revenue or its related term are showing as below:

XTAE:EFNC' s EV-to-Revenue Range Over the Past 10 Years
Min: -13.36   Med: 5.57   Max: 105.17
Current: 79.89

During the past 11 years, the highest EV-to-Revenue of Erech Finance Cahalacha was 105.17. The lowest was -13.36. And the median was 5.57.

XTAE:EFNC's EV-to-Revenue is ranked worse than
95.16% of 826 companies
in the Medical Devices & Instruments industry
Industry Median: 3.02 vs XTAE:EFNC: 79.89

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-24), Erech Finance Cahalacha's stock price is ₪2.826. Erech Finance Cahalacha's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₪0.11. Therefore, Erech Finance Cahalacha's PS Ratio for today is 25.46.


Erech Finance Cahalacha EV-to-Revenue Historical Data

The historical data trend for Erech Finance Cahalacha's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Erech Finance Cahalacha EV-to-Revenue Chart

Erech Finance Cahalacha Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.23 16.01 9.33 4.92 96.19

Erech Finance Cahalacha Semi-Annual Data
Dec13 Dec14 Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.33 - 4.92 - 96.19

Competitive Comparison of Erech Finance Cahalacha's EV-to-Revenue

For the Medical Devices subindustry, Erech Finance Cahalacha's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Erech Finance Cahalacha's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Erech Finance Cahalacha's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Erech Finance Cahalacha's EV-to-Revenue falls into.



Erech Finance Cahalacha EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Erech Finance Cahalacha's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=22.529/0.282
=79.89

Erech Finance Cahalacha's current Enterprise Value is ₪22.53 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Erech Finance Cahalacha's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₪0.28 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Erech Finance Cahalacha  (XTAE:EFNC) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Erech Finance Cahalacha's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=2.826/0.111
=25.46

Erech Finance Cahalacha's share price for today is ₪2.826.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was ₪0.11.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Erech Finance Cahalacha EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Erech Finance Cahalacha's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Erech Finance Cahalacha (XTAE:EFNC) Business Description

Traded in Other Exchanges
N/A
Address
Yakov Eliav 5, Downtown, Jerusalem, ISR
Erech Finance Cahalacha Ltd, formerly Insuline Medical Ltd is a medical device company. It develops & markets technologies to the clinical effectiveness of devices & drugs for the treatment of diabetes. Its products include the InsuPatch device for insulin pump users, & the InsuPad device for injection users. The InsuPad is a company's flagship product.

Erech Finance Cahalacha (XTAE:EFNC) Headlines

No Headlines